MRFR Year End Sale
Halitosis Treatment Market Research Report- Forecast till 2027

Halitosis treatment market information: by type (pathologic halitosis, others), by indication (respiratory, liver, kidney, gastrointestinal, systemic, others), by diagnostic tests (halimeter, gas chromatography, BANA Test, β-galactosidase activity assay, others), by drug treatment (antacids, antiseptics, ranitidine, others) - forecast till 2027

ID: MRFR/Pharma/2493-CR | August 2017 | Region: Global | 153 Pages         

Halitosis Treatment market

Halitosis is a clinical condition characterized by unpleasant odor present in the mouth due to various periodontal and chronic diseases


By Type pathologic halitosis others
By Indication respiratory liver kidney gastrointestinal systemic others
By Diagnostic Tests halimeter gas chromatography BANA Test β-galactosidase activity assay others
By Drug Treatment antacids antiseptics ranitidine others

Key Players

  • Colgate-Palmolive Company (U.S)
  • All USA Partners LLC (U.S)
  • Dr. Harold Katz LLC (U.S)
  • Rowpar Pharmaceuticals Inc. (U.S)
  • Abbott (U.S)
  • Listerine (U.S)
  • AstraZeneca (U.S)


  • Rising incidence of periodontal disease
Speak to Analyst Request a Free Sample

Halitosis Treatment Market Overview

The halitosis treatment market will acquire a value of USD 22,153.4 billion by 2023, a healthy CAGR of 18.58 % in the forecast period between 2023 to 2027.

Halitosis is the health condition of bad breath, which is caused due to many reasons such as bad oral hygiene, crash diets, medication side effect, high alcohol consumption, GERD, lactose intolerance, smoking, diabetes, gum diseases, and others. This disease can generally lead to social restraints.

Other reasons for the condition are diet, lactose intolerance, poor health hygiene, medication, diabetes, GERD, and gum diseases. As this has become a global issue, the halitosis treatment market is noticing sheer demand across the world. A rise in cases of people suffering from halitosis and the growing awareness to prevent the disease is accelerating the market.

The concern among the youth generation and the advancement in diagnosis and treatment of the disease are progressing the market towards its excellent growth rate. The growth of the senior population and the rise of chronic disease concern like lungs, respiratory diseases, liver failure, and diabetes is helping the market to grow higher. Proper dental health care treatment facilities and medications are enhancing the market. The growing concern among various groups for periodontal diseases is another reason driving the market in the forecast period.

Key Players in the Halitosis Treatment Market

Some of key players profiled in the report are Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), AstraZeneca (U.S). The report for Halitosis treatment market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Figure 1 Global Halitosis Treatment Market by type, 2016 (% market share) Halitosis Treatment Market by type 1


The global halitosis treatment market is segmented on the basis type of halitosis, indication, diagnostic test and drug treatment.

On the basis of type of halitosis, the markets is segmented into pathological halitosis and others. Pathological halitosis is divided into oral pathological halitosis and extra oral pathological halitosis. Other types include physiological halitosis.

On the basis of indication, the market is segmented into respiratory, liver, kidney, gastrointestinal, systemic, and others. Respiratory segment is further sub-segmented into sinusitis, tuberculosis, emphysema, pharyngitis, pneumonia, and others. Liver segment is further sub-segmented into liver failure, gall bladder diseases, and others. Kidney segment is further sub-segmented into Uremia. Gastrointestinal segment is further sub-segmented into esophageal reflux, stomach cancer, malabsorption, and pharyngitis. Systemic segment is further sub-segmented into diabetes.

On the basis of diagnostic test, the market is segmented into halimeter, gas chromatography, BANA test, β-galactosidase activity assay, and other tests.

On the basis of drug treatment, the global halitosis treatment market is segmented into antacids, antiseptic, ranitidine and other drugs. Other drugs available of the treatment of halitosis are cetylpyridinium chloride and cimetidine. 

Regional analysis:

The global halitosis treatment market is segmented into four main regions namely America, Europe, Asia Pacific and Middle East & Africa.

The Americas account for a significant market share owing to rising prevalence of gum diseases and extensive use of oral care products such as toothpastes, mouth washes, mouth sprays, etc. In 2013, in the US, USD 810 million was spent for halitosis treatment.

Europe is the second largest market in the world whose growth is attributed to an increase in awareness regarding halitosis and products available for its treatment. Furthermore, increasing demand for new oral care products influence the market growth.

Asia Pacific region is expected to grow rapidly due to rising prevalence of chronic diseases such diabetes, respiratory diseases, kidney or liver failure with the increasing population. Rising geriatric population suffering from these diseases also contribute to the market growth.

In the Middle East & Africa, the market is expected to witness a moderate growth owing to poor economic conditions, and lack of awareness about oral health.

Recent Development

In May 2022

Bentodent, a D2C startup of eco-friendly oral care products. Offers FDA-approved, eco-friendly products. The SLS-free item is now available in India and Canada, Southeast Asia, the US, and Russia.

It has become an FDA-approved toothpaste and is free of SLS as it was found that the chemical is the main cause of stomach issues, canker sores, mouth ulcers, and mucosal irritation. This is why people have recurrent ulcers despite getting treated, which also leads to bad breath and mouth dryness.

Most kinds of toothpaste have a base of calcium carbonate. However, Bentodent uses Bentonite Clay, a cleanser used in Ayurveda, alongside natural ingredients like cardamom, betel leaf, mint, and charcoal.

Intended Audience


  • Dental care products manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities


Research Methodology Research methodology halitosis treatment marketsSources: Mayo Clinic, Healthline Media, U.S. Department of Health and Human Services MRFR Analysis

Report Scope:

Report Attribute/Metric Details
  Market Size   2023: USD 22,153.4 Billion
  CAGR   2017-2023: 18.58%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type of Halitosis, Indication, Diagnostic Test and Drug Treatment
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), AstraZeneca (U.S)
  Key Market Opportunities   Dental Health Care Products Manufacturer
  Key Market Drivers   Rising incidence of periodontal disease

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Halitosis Treatment Market is projected to grow at a 18.58% CAGR between 2020-2027.

Perfusion Imaging Market predicted to touch USD 22,153.4 billion by 2023.

The Americas is expected to lead the Halitosis Treatment Market.

Rising incidence of periodontal disease is adding market growth.

Different strategies used by market players to create a dominance in the Halitosis Treatment Market include product launches, R&D, collaborations, and mergers.